Premium
Interferon alpha in the therapy of CML
Author(s) -
Talpaz M.,
Kantarjian H.,
Kurzrock R.,
Gutterman J. U.
Publication year - 1991
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.1991.tb08117.x
Subject(s) - alpha interferon , medicine , alpha (finance) , oncology , interferon , cancer , cancer therapy , immunology , surgery , construct validity , patient satisfaction
This paper summarizes the experience with interferon alpha (IFNα) as single‐agent therapy and in combination gathered at M. D. Anderson Cancer Center. It also covers some of the laboratory research associated with these clinical studies.